Skip To Main Content

Pilot study of the effectiveness of a pharmacist-led tobacco cessation mobile health clinic in a rural setting

Colin S. Frank, PharmD, TTS, Amy Fanous, PharmD, BCACP, TTS, Michael J. Rush, PharmD, CDE, BCACP, TTS, Karen L. Kier, Ph.D., M.Sc., R.Ph., BCPS, BCACP, TTS, Bree Meinzer, PharmD, TTS
Ohio Northern University
Institution if not ONU: 


Tobacco use is the leading cause of preventable death in America. Although there has been significant improvement in lowering the rates of tobacco use, rural areas continue to have a greater rate of tobacco use. This is due to limited treatment options from a lack of transportation, lack of access to healthcare services, and a low socioeconomic status. Pharmacists utilized in mobile health clinic would effectively eliminate these barriers. The purpose of this study is to determine the effectiveness of a pharmacist providing tobacco cessation services through a mobile health clinic in a rural setting.


The study is IRB approved. Current tobacco users will be recruited from five rural communities to participate in the study. Participants will be required to have an initial appointment at a mobile health clinic event where data will be collected on tobacco use, past medical history, current, medications, and vitals will be collected. At the initial visit, participants will choose a quit date and select whether they will use nicotine replacement therapy, prescription medications, or counseling alone. Additionally, participants will be asked to complete a survey assessing the effectiveness of various marketing strategies, reasons for starting tobacco cessation, and perceived barriers to tobacco cessation. Participants will receive a phone call follow up on their set quit date followed by appointments at weeks 1, 4, 8, and 12 weeks of therapy either by a phone call or an on-site follow up. At each appointment, participants will be assessed on tobacco use, symptoms of nicotine withdrawal, and side effects of medications. Effectiveness will be measured by the percent of patients who have not used any tobacco products after 12 weeks. Patient documentation will be securely stored at the primary clinic site. Data utilized in the study will be de-identified and stored in a password protected spreadsheet. 



American Society of Health-System Pharmacists Midyear Clinical Meeting
PDF icon frank_tobacco_cessation_poster.pdf1.23 MB